NEW YORK (GenomeWeb News) – A Rockefeller University researcher plans to use a $1.3 million grant from the National Institutes of Health to develop a novel method for applying high-throughput sequencing to the study of human immune system function.

Brad Rosenberg, a biomedical fellow at Rockefeller, was one of 14 investigators chosen by the NIH Office of the Director to receive a total of $25.9 million under its Early Independence award program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.